￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Special targeted drug for lung cancer-vandetanib

2025-10-19 11:44:20

Check Details
How much will a box of ceritinib cost after medical insurance reimbursement in 2021?

2025-10-19 11:44:20

Check Details
Analysis of the efficacy and adverse reactions of ramucirumab in the treatment of lung cancer

2025-10-19 11:44:20

Check Details
How much does it cost to take the lung cancer RET mutation-targeting drug vandetanib for a month?

2025-10-19 11:44:20

Check Details
Ceritinib is a second-generation anti-cancer drug for anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer_ Kanghule

2025-10-19 11:44:20

Check Details
The difference between ramucirumab and bevacizumab_Canghule

2025-10-19 11:44:20

Check Details
Can lung cancer patients shrink tumors by taking vandetanib?

2025-10-19 11:44:20

Check Details
The effect of ceritinib treatment on non-small cell lung cancer patients who have progressed or are intolerant to crizotinib

2025-10-19 11:44:20

Check Details
How much does a cycle of ramucirumab cost for lung cancer?

2025-10-19 11:44:20

Check Details
Can entrectinib be used to treat ROS1 mutated lung cancer?

2025-10-19 11:44:20

Check Details
Will ramucirumab be included in the national medical insurance in China in 2021?

2025-10-19 11:44:20

Check Details
Effectiveness data of ceritinib in first-line treatment of ALK-positive non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Category
相关知识